PMID: 6992076May 1, 1980Paper

Acute nonlymphocytic leukemia

Pediatric Clinics of North America
N L KobrinskyM E Nesbit

Abstract

The discovery of cytosine arabinoside, and then the anthrocycline antibiotics, 6-thioguanine, vincristine, cyclophosphamide, and other drugs, has added to the armamentarium of known effective agents. The use of combination chemotherapy, the recognition of the need during induction for virtual marrow aplasia to obtain a remission, and recognition of the predilection of the disease for the central nervous system requiring prophylaxis constitute major advances. The impediment to long-term survival is the lack of effective maintenance therapy.

References

Jan 29, 1976·The New England Journal of Medicine·I TsukimotoB C Lampkin
Oct 25, 1975·Lancet·A De Ca ChapelleP Teesdale
Jan 13, 1977·Nature·P RuutuA de la Chapelle
Mar 1, 1978·British Journal of Haematology·L M Walker, R M Sandler
Sep 1, 1977·British Journal of Haematology·G BoetiusC Haanen
Jul 15, 1976·International Journal of Cancer. Journal International Du Cancer·F MitelmanL Brandt
Dec 8, 1973·Lancet·P PetitP Fondu
Feb 1, 1974·The Journal of Pediatrics·L G MacdougallJ M Judisch
May 1, 1980·Pediatric Clinics of North America·N L KobrinskyM E Nesbit
Jul 1, 1996·Current Opinion in Hematology·C P Leith, C L Willman

❮ Previous
Next ❯

Citations

Jan 1, 1983·Human Genetics·G P PuchkovaI S Peterson
Nov 1, 1989·Indian Journal of Pediatrics·R AbeS Kariyone
Feb 15, 2002·International Journal of Hematology·Hiroyuki FujisakiJunichi Hara
May 1, 1980·Pediatric Clinics of North America·N L KobrinskyM E Nesbit
Jun 1, 1983·Cancer Genetics and Cytogenetics·M SasakiT Tomiyasu
Jan 1, 1985·Cancer Genetics and Cytogenetics·Y S Li
Apr 15, 1986·Cancer Genetics and Cytogenetics·E PaiettaP H Wiernik
Jul 1, 1991·Cancer Genetics and Cytogenetics·N BuninB Lange
Oct 1, 1992·Cancer Genetics and Cytogenetics·Z ChenA A Sandberg
Sep 1, 1992·Cancer Genetics and Cytogenetics·W S StanleyP Dinndorf
Nov 1, 1992·Cancer Genetics and Cytogenetics·F SoléJ Sans-Sabrafen
Mar 1, 1997·Blood Reviews·E Johnson, F E Cotter
Nov 5, 1981·The New England Journal of Medicine·M Gyger, Y Bonny
Jan 1, 1986·Critical Reviews in Oncology/hematology·M L Bernstein, M J Vekemans
Jan 20, 2000·Baillière's Clinical Haematology·F E Cotter
Oct 1, 1981·British Journal of Haematology·C A SieffS D Lawler
May 1, 1988·British Journal of Haematology·J P EvansJ M Chessells
Nov 1, 1985·British Journal of Haematology·L C ChanM F Greaves
Dec 1, 1986·British Journal of Haematology·G F SanzM A Sanz
Mar 1, 1995·Leukemia & Lymphoma·J Boultwood, C Fidler
Jul 15, 1986·Cancer·D C Arthur
Mar 1, 1990·American Journal of Medical Genetics·D M GilchristS P Creighton
Jan 1, 1982·Archives of Virology·C R Pringle
Jan 1, 1981·Naunyn-Schmiedeberg's Archives of Pharmacology·U Havemann, K Kuschinsky
Dec 1, 1982·American Journal of Hematology·M GygerL Forest
Apr 1, 1985·Hematological Oncology·S H SwerdlowR D Collins
May 23, 2008·Pediatric Emergency Care·Jonathan Singer, Susan Henry
Jan 1, 1982·Pediatric Cardiology·N L KobrinskyW Krivit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.